129 related articles for article (PubMed ID: 11205462)
21. The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21).
Ha CS; Tucker SL; Lee MS; McLaughlin P; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):727-32. PubMed ID: 11172955
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors and a predictive model of follicular lymphoma: a 25-year study at a single institution in Japan.
Katsumata N; Matsuno Y; Nakayama H; Takenaka T; Kobayashi Y; Takeyama K; Narabayashi M; Fukushima T; Yokozawa T; Nakata M; Tajima K; Ikeda H; Tobinai K
Jpn J Clin Oncol; 1996 Dec; 26(6):445-54. PubMed ID: 9001350
[TBL] [Abstract][Full Text] [Related]
23. Primary peripheral nodal lymphoma in children.
Wollner N; Exelby P; Lindsley KL; Lieberman P; Filippa D; Heller G
Cancer; 1993 Jun; 71(11):3670-9. PubMed ID: 8490916
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.
Berglund A; Enblad G; Carlson K; Glimelius B; Hagberg H
Eur J Haematol; 2000 Jul; 65(1):17-22. PubMed ID: 10914935
[TBL] [Abstract][Full Text] [Related]
25. Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Liu Q; Fayad L; Cabanillas F; Hagemeister FB; Ayers GD; Hess M; Romaguera J; Rodriguez MA; Tsimberidou AM; Verstovsek S; Younes A; Pro B; Lee MS; Ayala A; McLaughlin P
J Clin Oncol; 2006 Apr; 24(10):1582-9. PubMed ID: 16575009
[TBL] [Abstract][Full Text] [Related]
26. Follicular lymphoma: prognostic factors for response and survival.
Gallagher CJ; Gregory WM; Jones AE; Stansfeld AG; Richards MA; Dhaliwal HS; Malpas JS; Lister TA
J Clin Oncol; 1986 Oct; 4(10):1470-80. PubMed ID: 3531422
[TBL] [Abstract][Full Text] [Related]
27. Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial.
Watanabe T; Tobinai K; Wakabayashi M; Morishima Y; Kobayashi H; Kinoshita T; Suzuki T; Yamaguchi M; Ando K; Ogura M; Taniwaki M; Uike N; Yoshino T; Nawano S; Terauchi T; Hotta T; Nagai H; Tsukasaki K;
Lancet Haematol; 2018 Nov; 5(11):e520-e531. PubMed ID: 30389034
[TBL] [Abstract][Full Text] [Related]
28. Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
Decaudin D; Lepage E; Brousse N; Brice P; Harousseau JL; Belhadj K; Tilly H; Michaux L; Chèze S; Coiffier B; Solal-Céligny P
J Clin Oncol; 1999 Aug; 17(8):2499-505. PubMed ID: 10561315
[TBL] [Abstract][Full Text] [Related]
29. Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial.
Avilés A; Delgado S; Fernández R; Talavera A; Neri N; Huerta-Guzmán J
Eur J Haematol; 2002 Mar; 68(3):144-9. PubMed ID: 12068794
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
Koffi G; Kouakou B; Ndiaye FS; Ndathz E; Sanogo I; Sangare A
Bull Cancer; 2007 Oct; 94(10):902-6. PubMed ID: 17964984
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
Barzenje DA; Cvancarova Småstuen M; Liestøl K; Fosså A; Delabie J; Kolstad A; Holte H
PLoS One; 2015; 10(7):e0131158. PubMed ID: 26147646
[TBL] [Abstract][Full Text] [Related]
32. Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21).
Ha CS; Lee MS; McLaughlin P; Tucker SL; Wilder RB; Cox JD; Cabanillas F
Cancer J; 2004; 10(1):49-53. PubMed ID: 15000495
[TBL] [Abstract][Full Text] [Related]
33. [Current clinical aspects of follicular lymphoma].
Dreyling M
Ther Umsch; 2010 Oct; 67(10):511-6. PubMed ID: 20886457
[TBL] [Abstract][Full Text] [Related]
34. Long-term results with radiotherapy for Stage I-II follicular lymphomas.
Wilder RB; Jones D; Tucker SL; Fuller LM; Ha CS; McLaughlin P; Hess MA; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1219-27. PubMed ID: 11728680
[TBL] [Abstract][Full Text] [Related]
35. Ocular adnexal follicular lymphoma: a multicenter international study.
Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
[TBL] [Abstract][Full Text] [Related]
36. The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases.
Rigacci L; Federico M; Martelli M; Zinzani PL; Cavanna L; Bellesi G; Merli F; Alterini R; Petrucci MT; Tani M; Liberati AM; Vitolo U; Pavone V; Cuneo A; Chisesib T; Brugiatelli M;
Leuk Lymphoma; 2003 Nov; 44(11):1911-7. PubMed ID: 14738142
[TBL] [Abstract][Full Text] [Related]
37. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
Mac Manus MP; Hoppe RT
J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Sarris AH; Braunschweig I; Medeiros LJ; Duvic M; Ha CS; Rodriguez MA; Hagemeister FB; McLaughlin P; Romaguera J; Cox J; Cabanillas F
J Clin Oncol; 2001 Jan; 19(2):398-405. PubMed ID: 11208831
[TBL] [Abstract][Full Text] [Related]
39. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
[TBL] [Abstract][Full Text] [Related]
40. Treatment of prognosis of primary breast lymphoma: a review of 13 cases.
Lyons JA; Myles J; Pohlman B; Macklis RM; Crowe J; Crownover RL
Am J Clin Oncol; 2000 Aug; 23(4):334-6. PubMed ID: 10955857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
